EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Kindred Biosciences's enterprise value is $369.55 Mil.
Kindred Biosciences's Revenue for the trailing twelve months (TTM) ended in Jun. 2021 was $7.93 Mil. Therefore, Kindred Biosciences's EV-to-Revenue for today is 46.63.
The historical rank and industry rank for Kindred Biosciences's EV-to-Revenue or its related term are showing as below:
KIN'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.05 Med: 46.41 Max: 613.91
Current: 46.63
During the past 9 years, the highest EV-to-Revenue of Kindred Biosciences was 613.91. The lowest was 2.05. And the median was 46.41.
KIN's EV-to-Revenue is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.37
vs KIN: 46.63
The historical data trend for Kindred Biosciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kindred Biosciences's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Kindred Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kindred Biosciences's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kindred Biosciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Kindred Biosciences's EV-to-Revenue falls into.
Kindred Biosciences's current Enterprise Value is $369.55 Mil.
Kindred Biosciences's Revenue for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kindred Biosciences's share price for today is $9.25.
Kindred Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.19.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kindred Biosciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Kindred Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Kindred Biosciences (Kindred Biosciences) Business Description
Kindred Biosciences Inc is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. The company identifies targets that have already demonstrated safety and efficacy in humans and develop therapeutics based on these validated targets for dogs and cats. It has a pipeline of novel biologics in development across many therapeutic classes, alongside biologics manufacturing capabilities and a broad intellectual property portfolio.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KIN has been successfully added to your 